About Invictus Pharma LLP
Data last updated:
Invictus Pharma LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAF-7351. Its GSTIN is 27AAFFI7260K1Z2 (Maharashtra).
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Vishal Machindranath Patil and Pranal Harishchandra Shinde.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹33.46 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.22 Cr (net margin 3.6%) and EBITDA of ₹2.35 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 76% over three years and 136% over five years.
As per MCA filings, the LLP has open charges of ₹9.1 Cr on record.
For more details, the LLP can be reached via its website invictuspharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1008 10th Floor Plot 5/209 E2 Sky Flama, Tokersey Jivraj Road Dosti Flamingo Sewree, Mumbai, Maharashtra, India – 400015
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Invictus Pharma LLP FY 2025 filings available
Invictus Pharma LLP reported revenue of ₹33.46 Cr (up 11% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Invictus Pharma LLP
Revenue has grown at a compounded annual rate (CAGR) of 136% over five years, including 11% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Invictus Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹1.22 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Invictus Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 3.6% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Invictus Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Invictus Pharma LLP
Auditor information for Invictus Pharma LLP provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Designated Partners of Invictus Pharma LLP
Invictus Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Machindranath Patil Also directs: Goodman Vetcare Private Limited, Inovora Resources Private Limited | Designated Partner | 17 Feb 2016 | 10 Years 7 Months | Current |
| Pranal Harishchandra Shinde | Designated Partner | 17 Feb 2016 | 10 Years 7 Months | Current |
Ownership and Shareholding of Invictus Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Invictus Pharma LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 2023 | Axis Bank Limited | ₹10.1 Lakh | Open |
| 04 Feb 2023 | Icici Bank Limited | ₹9 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Invictus Pharma LLP
Employment history and EPFO contributions of people linked to Invictus Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Invictus Pharma LLP
Invictus Pharma LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Pranal Harishchandra Shinde was appointed as Designated Partner on 17 Feb 2016.
Credit Ratings, Litigation & Regulatory Alerts for Invictus Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Invictus Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Invictus Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Invictus Pharma LLP
Invictus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFFI7260K1Z2 | Maharashtra | Active | 24 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Invictus Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invictus Pharma LLP
Invictus Pharma is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2016 (10+ years old) and is registered under LLPIN AAF-7351.
Invictus Pharma reported revenue of ₹33.46 Cr for FY 2023 (up 11% YoY).
Invictus Pharma has 2 current designated partners:
- Vishal Machindranath Patil - Designated Partner
- Pranal Harishchandra Shinde - Designated Partner
Invictus Pharma reported a net profit of ₹1.22 Cr (net margin 3.6%) and EBITDA of ₹2.35 Cr (EBITDA margin 7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Invictus Pharma is 76% over three years and 136% over five years. In the latest year (FY 2023) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Invictus Pharma is 27AAFFI7260K1Z2, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Invictus Pharma is AAF-7351. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Invictus Pharma was incorporated on 17 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Pranal Harishchandra Shinde was appointed as Designated Partner on 17 Feb 2016. Vishal Machindranath Patil was appointed as Designated Partner on 17 Feb 2016.
Yes, Invictus Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).